Martín Durlach, Agustín Manchado Bruno, Julio C Rotondaro, Marina Khoury, Juan P Suarez
{"title":"[Persistent symptoms in healthcare workers recovered from COVID-19].","authors":"Martín Durlach, Agustín Manchado Bruno, Julio C Rotondaro, Marina Khoury, Juan P Suarez","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>There is no consensus on the definition of post-acute COVID-19 syndrome. Current definitions do not consider the number, severity or prior chronic symptoms. Our aims were to describe the frequency of \"new\" persistent symptoms (without taking into account those already present before pandemic) following acute COVID-19 and compare with those who did not present the disease.</p><p><strong>Materials and methods: </strong>We collected Information on 19 symptoms at two points: pre-pandemic and at survey time, through a self-administered survey targeted at health workers working in person during the pandemic.</p><p><strong>Exclusion criteria: </strong>acute COVID-19 (or within 21 days of the initial symptom). All COVID-19 participants had previous PCR-confirmed diagnosis.</p><p><strong>Results: </strong>Among 249 participants, 73 (29.3%) had had a diagnosis of COVID-19 and 176 (70.7%) had not. 43.8% reported at least one pre-pandemic symptom, with no significant differences between groups (44.3% vs. 42.5%, p=0.789). The median interval between COVID-19 acute illness and survey was 137 (range 38-164). The COVID-19 group reported higher frequency of \"new\" symptoms (39.7% vs. 12.5%, p=0.000, RR 3.17; 95% CI 1.96-5.14) with a risk difference of 27.2% (95% CI 14.98-39.46). 89% of the COVID-19 group with persistent symptoms had = 2 symptoms, and 69%, had = 3.</p><p><strong>Discussion: </strong>The 39.7% of the COVID-19 group had persistent \"new\" symptoms, 27% more than the nonCOVID group. It is important to unify current definitions of post-COVID syndrome and consider including other aspects such as number, severity prior chronic symptoms.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 4","pages":"734-742"},"PeriodicalIF":0.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina-buenos Aires","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: There is no consensus on the definition of post-acute COVID-19 syndrome. Current definitions do not consider the number, severity or prior chronic symptoms. Our aims were to describe the frequency of "new" persistent symptoms (without taking into account those already present before pandemic) following acute COVID-19 and compare with those who did not present the disease.
Materials and methods: We collected Information on 19 symptoms at two points: pre-pandemic and at survey time, through a self-administered survey targeted at health workers working in person during the pandemic.
Exclusion criteria: acute COVID-19 (or within 21 days of the initial symptom). All COVID-19 participants had previous PCR-confirmed diagnosis.
Results: Among 249 participants, 73 (29.3%) had had a diagnosis of COVID-19 and 176 (70.7%) had not. 43.8% reported at least one pre-pandemic symptom, with no significant differences between groups (44.3% vs. 42.5%, p=0.789). The median interval between COVID-19 acute illness and survey was 137 (range 38-164). The COVID-19 group reported higher frequency of "new" symptoms (39.7% vs. 12.5%, p=0.000, RR 3.17; 95% CI 1.96-5.14) with a risk difference of 27.2% (95% CI 14.98-39.46). 89% of the COVID-19 group with persistent symptoms had = 2 symptoms, and 69%, had = 3.
Discussion: The 39.7% of the COVID-19 group had persistent "new" symptoms, 27% more than the nonCOVID group. It is important to unify current definitions of post-COVID syndrome and consider including other aspects such as number, severity prior chronic symptoms.
关于COVID-19急性后综合征的定义尚未达成共识。目前的定义没有考虑数量、严重程度或既往慢性症状。我们的目的是描述急性COVID-19后“新的”持续症状的频率(不考虑大流行前已经出现的症状),并与未出现疾病的患者进行比较。材料和方法:我们通过一项针对大流行期间亲自工作的卫生工作者的自我管理调查,在大流行前和调查时两个时间点收集了19种症状的信息。排除标准:急性COVID-19(或出现初始症状后21天内)。所有COVID-19参与者之前都有pcr确诊。结果:249名参与者中,73名(29.3%)被诊断为COVID-19, 176名(70.7%)未被诊断为COVID-19。43.8%的人报告了至少一种大流行前症状,组间无显著差异(44.3%对42.5%,p=0.789)。COVID-19急性疾病与调查的中位间隔为137(范围38-164)。COVID-19组报告出现“新”症状的频率更高(39.7%对12.5%,p=0.000, RR 3.17;95% CI 1.96-5.14),风险差异为27.2% (95% CI 14.98-39.46)。有持续症状的COVID-19组中,89%有2种症状,69%有3种症状。讨论:39.7%的COVID-19组有持续的“新”症状,比非covid组多27%。重要的是要统一covid后综合征的现有定义,并考虑纳入其他方面,如既往慢性症状的数量、严重程度。